CD8A and cancer: These findings indicate that abnormal expression of MK is considered to be an important molecular mechanism in the obstruction of immunotherapeutic responses, possibly through the alternation of CD8+ T cell and macrophage population, and also one of the causes of drug resistance in cancer patients complicated with COVID-19.